Safety and clinical activity of atezolizumab plus erlotinib in patients with non-small-cell lung cancer

  1. Rudin, C.M.
  2. Cervantes, A.
  3. Dowlati, A.
  4. Besse, B.
  5. Ma, B.
  6. Costa, D.B.
  7. Schmid, P.
  8. Heist, R.
  9. Villaflor, V.M.
  10. Spahn, J.
  11. Li, S.
  12. Cha, E.
  13. Riely, G.J.
  14. Gettinger, S.
Revue:
ESMO Open

ISSN: 2059-7029

Année de publication: 2023

Volumen: 8

Número: 2

Type: Article

DOI: 10.1016/J.ESMOOP.2023.101160 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus